Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.3K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.3K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.7K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.7K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S1 guideline sweat gland carcinoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.

International journal of cancer·2026
Same author

Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.

International journal of cancer·2026
Same author

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Cancers·2026
Same author

Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response.

Nature communications·2026
Same author

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

The British journal of dermatology·2026

Related Experiment Video

Updated: Dec 10, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.

Ihor Arkhypov1,2, Samantha Lasser1,2, Vera Petrova1,2

  • 1Skin Cancer Unit, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

International Journal of Molecular Sciences
|September 4, 2020
PubMed
Summary

Tumor-derived extracellular vesicles (EV) influence myeloid cells, promoting cancer progression and metastasis. These vesicles can alter myeloid cell differentiation, suppress anti-tumor immunity, and contribute to pre-metastatic niche formation.

Keywords:
cancerextracellular vesiclesimmunosuppressionmyeloid cells

More Related Videos

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.2K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.5K

Related Experiment Videos

Last Updated: Dec 10, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.9K
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

7.2K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.5K

Area of Science:

  • Cancer Biology
  • Immunology
  • Cell Biology

Background:

  • Extracellular vesicles (EVs) mediate intercellular communication, carrying proteins, RNA, and DNA.
  • Tumor-derived EVs (TEVs) contain hypoxia-induced factors and microRNAs that promote cancer angiogenesis, invasion, and metastasis.
  • Myeloid cells, crucial for immune responses, have impaired differentiation and function in cancer, often promoting tumor growth.

Purpose of the Study:

  • To review the complex interactions between tumor-derived EVs and myeloid cells.
  • To elucidate how TEVs modulate myeloid cell differentiation and function in the tumor microenvironment.
  • To discuss the role of TEVs in immune suppression and pre-metastatic niche formation.

Main Methods:

  • Literature review of studies investigating EV-myeloid cell interactions in cancer.
  • Analysis of TEV cargo molecules and their impact on myeloid cell signaling pathways.
  • Examination of TEV effects on myeloid cell differentiation, including myeloid-derived suppressor cells (MDSCs).

Main Results:

  • TEVs can induce myeloid progenitor differentiation into immunosuppressive MDSCs.
  • TEVs augment the suppressive capacity of existing MDSCs.
  • Mature myeloid cells (monocytes, macrophages, dendritic cells, granulocytes) acquire protumorigenic phenotypes upon TEV uptake, although TEV delivery of tumor antigens can enhance dendritic cell immunostimulatory capacity.

Conclusions:

  • TEV-myeloid cell crosstalk is diverse and complex, significantly impacting cancer progression.
  • Myeloid cells play a central role in EV-mediated pre-metastatic niche formation.
  • Understanding these interactions is crucial for developing novel cancer therapies targeting the tumor microenvironment.